SynergyMed Cancer Treatment Technology

Ground Breaking Cancer Treatment: Tumors Vanish Within Few Days

Print
Claim My Business
Security Type
CAFES
Categories
Technology, Retail, Healthcare & Medical, Education, Financial Services, Community & Lifestyle
Min Investment
$100
Location
Boston, , MA
No. Investors
311

Key Deal Facts

Successful studies on mice and dogs
Aim to enter veterinary market by Q3 2025. Targeting FDA approval & human commercialization by 2026
$0.5 Billion projected revenue within 5 years (not guaranteed)
Received awards and recognitions from 6 national and international startup competitions and events
Patent-pending technology
Available CPT Codes for reimbursement by Medicare and commercial insurances
Commercial product near completion and certification
Building collaborations with leading U.S. institutions (Tufts, Harvard, ...)

Management Team / Advisory Board Bios

Anan Copty CEO25+ years of technical & leadership experiences,
RMD: Radiation Monitoring Devices, Intel: Biochips, Harvard Medical School: MRI, Yahya Dajani VP of Business DevelopmentMedical Technology Entrepreneur. Co-founded NCA Monitoring Technologies & D&O LLC
ADNOC Oil Company
Corporate Planning, Finance, Performance, and Business Development, Daniel Kacher, Ph.D.Director of Clinical Studies and Product DevelopmentPh.D. in Biomedical Engineering
25 years at Brigham and Women’s Hospital, Robert Roy, MBA, BSEE/BSMEVP of Marketing, Sales35+ years of senior-level management in medical device companies, Mimi Copty, MHACOO25+ years of project management & leadership experiences in health organizations in the US and internationally
Amount Raised : $369,547
Reveal the Score by Voting
_
Additional ratings from other users are needed to determine a viable CrowdScore for this deal.
The "CrowdScore" for this deal is determined by user ratings and other factors using our proprietary algorithm.
The overall viability and scalability of the business concept as well as the ability to drive the concept to profitability over time.
Business Idea
The progress made thus far in demonstrating that the business has viability, a customer base or other business traction.
Business Traction
The experience of the management team in running, scaling and/or exiting a business that required similar skills to execute the business plan.
Management Team
The value of the company compared to similar companies raising money from investors.
Valuation

Security Description

A CAFES (Contract and Future Equity Stake) can convert into different types of equity upon a Triggering Event, such as: common or preferred stock for a corporation, limited partnership interest for a limited partnership and membership interest for a limited liability company. At the time of the Triggering Event, the specific rights and limitations associated with the equity stake being issued to the investors will be determined and disclosed by the Entrepreneur.

Research Reports

No reports have been submitted

Become a Reporter

0 Comments